Stock data
Opus Genetics, Inc. (IRD)
Opus Genetics, Inc. (IRD) reported revenue of US$14.20M and net income of -US$49.59M for fiscal 2025. The figures below come from the company's SEC filings.
Annual results
Data as of 2025-12-31
| Fiscal year | Revenue | Gross profit | Operating income | Net income | Diluted EPS |
|---|---|---|---|---|---|
| 2025 | US$14.20M | — | -US$38.60M | -US$49.59M | — |
| 2024 | US$10.99M | — | -US$62.07M | -US$57.53M | — |
| 2023 | US$19.05M | — | -US$10.56M | -US$9.99M | — |
| 2022 | US$39.85M | — | US$18.23M | US$17.89M | — |
| 2021 | US$0.59M | — | -US$22.70M | -US$56.69M | — |
Quarterly results
Data as of 2026-06-30
| Quarter | Revenue | Net income | Diluted EPS |
|---|---|---|---|
| 2026-06-30 | US$0.76M | -US$8.10M | — |
| 2026-03-31 | US$2.16M | -US$65.53M | — |
| 2025-12-31 | US$3.87M | -US$16.52M | — |
| 2025-09-30 | US$3.08M | -US$17.45M | — |
| 2025-06-30 | US$2.88M | -US$7.42M | — |
| 2025-03-31 | US$4.37M | -US$8.19M | — |
| 2024-12-31 | US$4.30M | -US$35.13M | — |
| 2024-09-30 | US$3.87M | -US$7.53M | — |
Sources
- Source: SEC EDGAR company facts
Charts, drawing tools, and the P/E calculator are in the app, free to use.